You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epidermolysis Bullosa Simplex

Showing 1 - 25 of 346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Generalized Epidermolysis Bullosa Simplex Trial (AC-203, Vehicle)

Not yet recruiting
  • Generalized Epidermolysis Bullosa Simplex
  • (no location specified)
Oct 3, 2023

Epidermolysis Bullosa Simplex Trial in Redwood City (TolaSure Topical Gel, Vehicle Topical Gel)

Recruiting
  • Epidermolysis Bullosa Simplex
  • TolaSure Topical Gel
  • Vehicle Topical Gel
  • Redwood City, California
    Stanford University School of Medicine, Dermatology Department
Jul 18, 2022

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome Trial in Palo Alto (Sirolimus, 2%,

Completed
Has Results
  • Epidermolysis Bullosa Simplex
  • +2 more
  • Palo Alto, California
    Stanford University
Feb 25, 2022

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica Trial in Worldwide (INM-755

Recruiting
  • Epidermolysis Bullosa Simplex
  • +3 more
  • INM-755 (cannabinol) cream
  • Vehicle Cream
  • Salzburg, Austria
  • +6 more
Mar 30, 2022

Computational Drug Repurposing for All EBS Cases

Recruiting
  • Epidermolysis Bullosa
  • +5 more
  • Experimental Group
  • Palo Alto, California
    Pediatric Dermatology Clinic at Stanford Children's Hospital
Jan 11, 2022

Epidermolysis Bullosa Simplex Trial in France (Botulinic toxin, Placebo)

Recruiting
  • Epidermolysis Bullosa Simplex
  • Botulinic toxin
  • Placebo
  • Bordeaux, France
  • +3 more
Sep 3, 2021

The State of Sexual Development in Inherited Epidermolysis

Active, not recruiting
  • Dermatologic Disease
  • +7 more
  • Biochemical study of hormone levels
  • +3 more
  • Moscow, Russian Federation
    National Medical Research Center for Children's Health
Aug 26, 2021

Explore the Role of Gut Flora in Epidermolysis Bullosa

Recruiting
  • Epidermolysis Bullosa
  • +2 more
  • No intervention
  • Ventura, California
    ProgenaBiome
Sep 2, 2021

Epidermolysis Bullosa, Epidermolysis Bullosa Simplex Trial in Chicago, Chapel Hill, San Antonio (diacerein 1% ointment)

Completed
Has Results
  • Epidermolysis Bullosa
  • Epidermolysis Bullosa Simplex
  • diacerein 1% ointment
  • Chicago, Illinois
  • +2 more
Aug 26, 2020

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional Trial in Paris (CACIPLIQ20, Placebo)

    Not yet recruiting
    • Epidermolysis Bullosa Dystrophica
    • Epidermolysis Bullosa, Junctional
    • CACIPLIQ20
    • Placebo
    • Paris, France
      Hopital Necker - enfants malades
    Aug 17, 2023

    Recessive Dystrophic Epidermolysis Bullosa Trial (Spincare matrix)

    Not yet recruiting
    • Recessive Dystrophic Epidermolysis Bullosa
    • Spincare matrix
    • (no location specified)
    Jul 12, 2023

    Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)

    Not yet recruiting
    • Epidermolysis Bullosa
    • Minneapolis, Minnesota
      Masonic Cancer Center and Medical Center Minneapolis
    Apr 20, 2023

    Epidermolysis Bullosa, Oral Ulcer Trial in Santiago (Dentoxol mouthrinse dosages)

    Enrolling by invitation
    • Epidermolysis Bullosa
    • Oral Ulcer
    • Dentoxol mouthrinse dosages
    • Santiago, Región Metropolitana, Chile
      Facultad de Odontología, Universidad de Chile
    Apr 6, 2022

    Junctional Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa Trial in United States (RGN-137, Placebo)

    Terminated
    • Junctional Epidermolysis Bullosa
    • Dystrophic Epidermolysis Bullosa
    • Evanston, Illinois
    • +4 more
    Aug 18, 2022

    Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

    Not yet recruiting
    • Epidermolysis Bullosa
    • +2 more
    • EB-101 Surgical application of RDEB wounds
    • Redwood City, California
    • +1 more
    Feb 13, 2023

    Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

    Completed
    Has Results
    • Epidermolysis Bullosa
    • Serlopitant Tablet
    • Placebo Oral Tablet
    • Redwood City, California
      Stanford University
    Nov 30, 2022

    Artificial Intelligence Patient App for RDEB SCCs

    Recruiting
    • Epidermolysis Bullosa Dystrophica
    • online survey
    • Chicago, Illinois
      Department of Dermatology, Northwestern University Feinberg Scho
    May 3, 2023

    Growth Hormone in EB

    Not yet recruiting
    • Epidermolysis Bullosa Dystrophica
    • growth hormone level and insulin like growth factor 1
    • (no location specified)
    May 24, 2022

    Hereditary Epidermolysis Bullosa Trial in Paris (Cannabidiol)

    Not yet recruiting
    • Hereditary Epidermolysis Bullosa
    • Paris, France
      Hôpital Necker Enfants Malades
    Dec 7, 2022

    Recessive Dystrophic Epidermolysis Bullosa Trial in United States (FCX-007 (dabocemagene autoficel; see below for FCX-007

    Active, not recruiting
    • Recessive Dystrophic Epidermolysis Bullosa
    • FCX-007 (dabocemagene autoficel; see below for FCX-007 description)
    • Stanford, California
    • +4 more
    Aug 10, 2022

    Epidermolysis Bullosa Trial in Chicago (APR-TD011)

    Not yet recruiting
    • Epidermolysis Bullosa
    • APR-TD011
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Sep 6, 2022

    Recessive Dystrophic Epidermolysis Bullosa Trial in Worldwide (allo-APZ2-EB)

    Completed
    • Recessive Dystrophic Epidermolysis Bullosa
    • allo-APZ2-EB
    • Minneapolis, Minnesota
    • +5 more
    Oct 6, 2022

    Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, New York (PTR-01)

    Completed
    • Recessive Dystrophic Epidermolysis Bullosa
    • Redwood City, California
    • +1 more
    Nov 17, 2022

    Epidermolysis Bullosa Trial (allo-APZ2-OTS, Placebo)

    Not yet recruiting
    • Epidermolysis Bullosa
    • (no location specified)
    Jul 18, 2022